WHITEHAWK THERAPEUTICS, INC. Debt Securities, Available-for-sale, Amortized Cost
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Debt Securities, Available-for-sale, Amortized Cost of $189.79 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $189.79M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $122.81M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $145.33M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $162.21M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $189.79M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $122.81M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $145.33M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $162.21M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $176.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $230.81M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $46.04M 10-K · filed 2026-03-12 |
| 2024-09-30 | $61.84M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $77.27M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $86.42M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $108.11M 10-K · filed 2025-03-28 |
| 2023-09-30 | $118.83M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $133.77M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $140.81M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $165.69M 10-K · filed 2024-03-13 |
| 2022-09-30 | $176.09M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |